{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005317"
  },
  "Experiment Method": [
    {
      "Assay Method": "2D-DIGE",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Differentiated SH-SY5Y cells overexpressing WT or A53T alpha-synuclein and control cells",
        "Description": "Cells were used to compare proteomic profiles between WT, A53T, and control conditions."
      },
      "Readout": {
        "type": "Quantitative",
        "description": [
          {
            "variant": "NM_000340.2:c.158C>T",
            "effect": "A53T mutation is associated with altered proteomic profiles, including changes in HSPA9, NDUFS1, DLAT, and ATP5A1 expression."
          }
        ]
      },
      "Replicates": "Not explicitly stated, but standard biological replicates are assumed.",
      "Controls": "Control cells without alpha-synuclein overexpression.",
      "Statistical Analysis": "ANOVA for comparing proteomic profiles between groups.",
      "Thresholds": {
        "normal": "Standard thresholds for proteomic changes (e.g., ≥1.5-fold change in protein abundance) are assumed.",
        "abnormal": "Significant deviations from control proteomic profiles are considered abnormal."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "LC-MS/MS",
      "Material used": {
        "Material Source": "Proteomic samples from 2D-DIGE experiments",
        "Material Name": "Protein extracts from SH-SY5Y cells overexpressing WT or A53-T alpha-synuclein",
        "Description": "Used for identifying specific proteins differentially expressed in A53T versus WT conditions."
      },
      "Readout": {
        "type": "Qualitative/Quantitative",
        "description": [
          {
            "variant": "NM_000340.2:c.158C>T",
            "effect": "A53T mutation is associated with identification of 63 differentially expressed proteins, with 77% of changes observed in WT samples."
          }
        ]
      },
      "Replicates": "Not explicitly stated, but standard technical replicates are assumed.",
      "Controls": "Control samples from cells without alpha-synuclein overexpression.",
      "Statistical Analysis": "ANOVA for protein abundance comparisons.",
      "Thresholds": {
        "normal": "Standard thresholds for protein identification (e.g., ≥95% confidence in peptide identification) are assumed.",
        "abnormal": "Proteins with significant differential expression (e.g., ≥1.5-fold change) are considered abnormal."
      },
      "Approved Assay": "Yes"
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Protein extracts from SH-SY5Y cells overexpressing WT or A53T alpha-synuclein",
        "Material Name": "HSPA9, NDUFS1, DLAT, ATP5A1",
        "Description": "Used to validate proteomic findings for specific proteins."
      },
      "Readout": {
        "type": "Quantitative",
        "description": [
          {
            "variant": "NM_000340.2:c.158C>T",
            "effect": "A53T mutation is associated with altered expression levels of HSPA9, NDUFS1, DLAT, and ATP5A1."
          }
        ]
      },
      "Replicates": "Not explicitly stated, but standard biological replicates are assumed.",
      "Controls": "Control samples from cells without alpha-synuclein overexpression.",
      "Statistical Analysis": "ANOVA for comparing protein expression levels between groups.",
      "Thresholds": {
        "normal": "Standard thresholds for Western blot (e.g., 50–100% of control expression) are assumed.",
        "abnormal": "Significant deviations from control (e.g., <30% or >150% of control) are considered abnormal."
      },
      "Approved Assay": "Yes"
    }
  ]
}